Pharmacotherapy of Movement Disorders in Children and Adolescents
The third edition of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association (DSM III) (APA, 1980) lists the following groups of movement disorders in children and adolescents: attention deficit disorder with and without hyperactivity, stereotyped movement disorders, and pervasive developmental disorders. The reasons the three disorders are grouped together here is that the children who suffer from these disorders have movements that are not under conscious control, and all become very self-conscious because of their movement disorders. These disorders are more responsive to pharmacotherapy than most other disorders of children and adolescents.
KeywordsMovement Disorder Tourette Syndrome Child Psychiatry Pervasive Developmental Disorder Attention Deficit Disorder
Unable to display preview. Download preview PDF.
- American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders, 3rd edi., Washington, DC.Google Scholar
- Fish, B., 1967, Organic therapies, in: Comprehensive Textbook of Psychiatry ( A. M. Freedman and H. I. Kaplan, eds.), p. 1460, Williams and Wilkins, Baltimore.Google Scholar
- Gualtieri, C. T., Quade, D., Hicks, R. E., 1984, et al.,Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents, Am. J. Psychiatry 141.2023.Google Scholar
- Langer, D. H., Rapaport, T. L., Brown, G. L., et al., 1983, Behavioral effects of carbidopa/ levodopa in hyperactive boys, J. Am. Acad. Child Psychiatry 21, 1: 10–18.Google Scholar
- Lucas, A. R., 1979, Tic: Gilles de la Tourette’s syndrome, in: Basic Handbook of Child Psychiatry, Vol. III, pp. 677–678, Basic Books, New York.Google Scholar
- Shayvitz, B. A., 1982, A Biochemical Model for Attention Deficit Disorder, p. 11, Abbott Pharmaceuticals, Chicago.Google Scholar